Your browser doesn't support javascript.
loading
Application of artificial intelligence in a real-world research for predicting the risk of liver metastasis in T1 colorectal cancer.
Han, Tenghui; Zhu, Jun; Chen, Xiaoping; Chen, Rujie; Jiang, Yu; Wang, Shuai; Xu, Dong; Shen, Gang; Zheng, Jianyong; Xu, Chunsheng.
Afiliación
  • Han T; Xijing Hospital, Airforce Medical University, Xi'an, China.
  • Zhu J; State Key Laboratory of Cancer Biology, Institute of Digestive Diseases, Xijing Hospital, Airforce Medical University, Xi'an, China.
  • Chen X; Department of General Surgery, The Southern Theater Air Force Hospital, Guangzhou, China.
  • Chen R; Department of General Surgery, The Southern Theater Air Force Hospital, Guangzhou, China.
  • Jiang Y; State Key Laboratory of Cancer Biology, Institute of Digestive Diseases, Xijing Hospital, Airforce Medical University, Xi'an, China.
  • Wang S; State Key Laboratory of Cancer Biology, Institute of Digestive Diseases, Xijing Hospital, Airforce Medical University, Xi'an, China.
  • Xu D; Ming Gang Station Hospital, Xi'an Institute of Flight of the Air Force, Minggang, China.
  • Shen G; School of Clinical Medicine, Xi'an Medical University, Xi'an, China.
  • Zheng J; Ming Gang Station Hospital, Xi'an Institute of Flight of the Air Force, Minggang, China.
  • Xu C; Division of Digestive Surgery, Xijing Hospital of Digestive Diseases, Airforce Medical University, Xi'an, China. zhangchy73@mail2.sysu.edu.cn.
Cancer Cell Int ; 22(1): 28, 2022 Jan 15.
Article en En | MEDLINE | ID: mdl-35033083
ABSTRACT

BACKGROUND:

Liver is the most common metastatic site of colorectal cancer (CRC) and liver metastasis (LM) determines subsequent treatment as well as prognosis of patients, especially in T1 patients. T1 CRC patients with LM are recommended to adopt surgery and systematic treatments rather than endoscopic therapy alone. Nevertheless, there is still no effective model to predict the risk of LM in T1 CRC patients. Hence, we aim to construct an accurate predictive model and an easy-to-use tool clinically.

METHODS:

We integrated two independent CRC cohorts from Surveillance Epidemiology and End Results database (SEER, training dataset) and Xijing hospital (testing dataset). Artificial intelligence (AI) and machine learning (ML) methods were adopted to establish the predictive model.

RESULTS:

A total of 16,785 and 326 T1 CRC patients from SEER database and Xijing hospital were incorporated respectively into the study. Every single ML model demonstrated great predictive capability, with an area under the curve (AUC) close to 0.95 and a stacking bagging model displaying the best performance (AUC = 0.9631). Expectedly, the stacking model exhibited a favorable discriminative ability and precisely screened out all eight LM cases from 326 T1 patients in the outer validation cohort. In the subgroup analysis, the stacking model also demonstrated a splendid predictive ability for patients with tumor size ranging from one to50mm (AUC = 0.956).

CONCLUSION:

We successfully established an innovative and convenient AI model for predicting LM in T1 CRC patients, which was further verified in the external dataset. Ultimately, we designed a novel and easy-to-use decision tree, which only incorporated four fundamental parameters and could be successfully applied in clinical practice.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: China